ResearchMoz

The US Pharmacy Benefit Management (PBM) Industry Report: 2013 Edition

Koncept Analytics
Published Date » 2014-02-18
No. Of Pages » 59
 In the US, a third party administrator of prescription drug program is known as a Pharmacy Benefit Manager (PBM). The primary responsibilities of a PBM include processing and paying prescriptions drug claim, developing and maintaining formulary, negotiating discounts and rebates with drug manufacturers and pharmacies. The US prescription volume has witnessed an unprecedented growth over the past few years and the same pattern is likely to continue in the near future. Therefore, through rebates from pharmaceutical manufacturers, price discounts from retails, and effective mail service pharmacies, the PBMs ceaselessly focus on enabling the plan sponsors and individuals to obtain prescribed drugs at lower prices. 
   
 In order to improve the value of drug benefit and manage the cost...
Table of Content

1. Overview
1.1 History of PBM
1.2 PBM Managers
1.3 Retail Dispensing Process & Flow of Funds
1.4 Mail Dispensing Process and Flow of Funds

2. The US PBM Market Size
2.1 PBM Market by Value
  • Market Value Growth
  • Breakdown by Dispensing Channels
2.1.1 Retail Channels
2.1.2 Institutional Channels
2.2 PBM Market by Volume
  • Market Volume Growth
  • Breakdown by Dispensing Channels
2.2.1 Retail Channels
2.2.2 Institutional Channels
2.3 Generic Drugs
  • Market Overview
  • Penetration Rate
2.4 Specialty Drugs

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Accelerating US Aging Population
3.1.2 Rising Incidences of Chronic and Infectious Diseases
3.1.3 Increasing Life Expectancy Rate in the US
3.1.4 Escalating Healthcare Expenditure in the US
3.1.5 Healthcare Reforms
3.1.6 Rising Pharmaceutical Sales
3.1.7 Ameliorating Economic Conditions
3.2 Trends and Developments
3.2.1 Rising Medicare Enrollments
3.2.2 Trends in Drug Prices
3.2.3 Generic Drug Utilization
3.2.4 Increased Acceptance of Specialty Drug
3.2.5 Medicaid Pharmacy Program Savings
3.2.6 Penetration of Unbranded Generic Drug Prescription
3.2.7 PBM Mergers and Acquisitions

4. Competitive Landscape
4.1 Competition by Prescription Volume
4.2 Competition by Claims
4.3 Competition by Lives Managed
4.4 Competition by Specialty Pharmacy Drug Spending
4.5 Competition by Health Plans
4.6 Analysis of PBMs Operating Statistics
4.7 Competition by Customer Segment Mix

5. Company Profiles
5.1 Express Script
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
  • Expansion through Acquisitions
  • Unremitting Focus on Innovation
5.2 CVS Caremark
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
  • Acquisitions and Collaborations
  • Focus on Geographic Expansion
5.3 Catamaran
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
  • Expansion of Customer Base
  • Broadening Services Portfolio

List of Tables


The US Dollar Spend by Retail Channels - In US$ Billions (2008-2012) 
The US Dollar Spend by Institutional Channels - In US$ Billions (2008-2012) 
Number of Prescription Dispensed via Retail Channels in the US - In Million (2008-2012) 
Potential Medicaid Pharmacy Program Savings for Top 10 States (2012-2021) 
Selected PBM M&A Transactions - in US$ million (1993–2012) 
EBITDA Multiples for Selected PBM transactions (2000-2012) 
Dollar Share of Leading PBMs by PBM Revenue (2013E) 
PBM Market Share Based on Adjusted Prescription Volume (2012) 
Adjusted Mail-Order Penetration (Q112-Q213) 
Generic Dispensing Rate (Q112-Q213) 
Revenue per Adjusted Rx (Q112-Q213) 
EBITDA per Adjusted Rx (Q112-Q213) 
PBM Profitability Metrics (2012) 

List of Figures


History of PBMs
Types of PBM Services
PBM Managers Formulary Structure
Retail Dispensing Process and Flow of Funds
Mail Dispensing Process and Flow of Funds
The US Prescription Drug Market – by Value (2008-2012) 
The US Prescription Drug Market by Dispensing Channels – by Value (2012) 
Percentage Share of the Dispensing Channels in the US Prescription Drug Market - by Value (2012) 
Percentage Share of Retail Dispensing Channels in the US Prescription Drug Market – by Value (2012) 
Percentage Share of Institutional Dispensing Channels in the US Prescription Drug Market – by Value (2012) 
The US Prescription Drug Market – by Volume (2012) 
The US Prescription Drug Market by Dispensing Channels – by Volume (2012) 
Percentage Share of the Dispensing Channels in the US Prescription Drug Market - by Volume (2012) 
Percentage Share of Retail Dispensing Channels in the US Prescription Drug Market – by Volume (2012) 
Number of Prescription Dispensed via Institutional Channels in the US (2008-2012) 
Penetration of Generic Drugs (2003-2013E) 
Estimated PBM Profitability of Generic versus Branded Scripts by Channel (2012) 
Estimated Brand Revenue Lost to Generic Launches (2012-2016E) 
Specialty Market Share by Dispensing Channels (2012) 
The US Aging Population (2008-2012) 
The US Life Expectancy Rate (2006-2013E) 
The US Healthcare Expenditure per Capita (2006-2012E) 
The US Pharmaceutical Sales (2010-2012) 
GNI of the US (2006-2012) 
Medicare Enrollments (2005-2014E) 
Drugs Price Index (2008-2013E) 
Specialty Drug Spending Trend (2012 & 2015E) 
Generic Drug Penetration Rate (2005-2013E) 
Percentage Share of Leading PBMs by PBM Revenue (2013E) 
Fortune 100 PBM Market Share (2012) 
Percentage Share of PBM on Adjusted Prescription Dispensed - Volume (2012) 
PBM Market Share by Claims (2014E) 
PBM Market Share by Lives Managed (2013E) 
Percentage Share of Specialty Pharmacy Drug Spending (2012) 
Top 35 Health Plan (Based on Lives) PBM Market Share (2012) 
PBMs Pro-forma Customer Segment Mix (2012) 
Revenue of Express Script by Business Segment (2012) 
Express Script Revenue and Net Income (2008-2012) 
CVS Caremark Business Revenue – by Segment (2012) 
CVS Caremark Revenue and Net Income (2008-2012) 
Catamaran’s Revenue by Business Segment (2012) 
Catamaran Revenue and Net Income (2008-2012) 

Upcoming Reports:

Poland: control valves market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the control valves market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the control valves market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of...
MTBE Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Methyl tertiary butyl ether (MTBE) is a colorless, volatile, flammable liquid majorly used as fuel component. MTBE is manufactured by catalytic reaction of isobutylene with methanol. MTBE is used as an octane buster in engines. It is also used as oxygenate to increase oxygen in gasoline. MTBE offers good blending properties and reduces the content of formaldehyde and benzene in gasoline. Additionally, it replaces lead compounds enhancing the anti-knocking properties of the fuel. It is also used as a laboratory reagent to extract compounds. It is also used as solvent to dissolve gallstones....
Poland: hydrochloric acid market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the hydrochloric acid market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the hydrochloric acid market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...